Table of Contents Chapter 1 Overview of Muscle Relaxant Drugs 1.1 Definition of Muscle Relaxant Drugs in This Report 1.2 Commercial Types of Muscle Relaxant Drugs 1.2.1 Skeletal Muscle Relaxant Drugs 1.2.2 Facial Muscle Relaxant Drugs 1.3 Downstream Application of Muscle Relaxant Drugs 1.3.1 Hospital Pharmacies 1.3.2 Retail Pharmacies 1.3.3 Other 1.4 Development History of Muscle Relaxant Drugs 1.5 Market Status and Trend of Muscle Relaxant Drugs 2013-2023 1.5.1 United States Muscle Relaxant Drugs Market Status and Trend 2013-2023 1.5.2 Regional Muscle Relaxant Drugs Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Muscle Relaxant Drugs in United States 2013-2017 2.2 Consumption Market of Muscle Relaxant Drugs in United States by Regions 2.2.1 Consumption Volume of Muscle Relaxant Drugs in United States by Regions 2.2.2 Revenue of Muscle Relaxant Drugs in United States by Regions 2.3 Market Analysis of Muscle Relaxant Drugs in United States by Regions 2.3.1 Market Analysis of Muscle Relaxant Drugs in New England 2013-2017 2.3.2 Market Analysis of Muscle Relaxant Drugs in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Muscle Relaxant Drugs in The Midwest 2013-2017 2.3.4 Market Analysis of Muscle Relaxant Drugs in The West 2013-2017 2.3.5 Market Analysis of Muscle Relaxant Drugs in The South 2013-2017 2.3.6 Market Analysis of Muscle Relaxant Drugs in Southwest 2013-2017 2.4 Market Development Forecast of Muscle Relaxant Drugs in United States 2018-2023 2.4.1 Market Development Forecast of Muscle Relaxant Drugs in United States 2018-2023 2.4.2 Market Development Forecast of Muscle Relaxant Drugs by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Muscle Relaxant Drugs in United States by Types 3.1.2 Revenue of Muscle Relaxant Drugs in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Muscle Relaxant Drugs in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Muscle Relaxant Drugs in United States by Downstream Industry 4.2 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in Major Countries 4.2.1 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in New England 4.2.2 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The Midwest 4.2.4 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The West 4.2.5 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The South 4.2.6 Demand Volume of Muscle Relaxant Drugs by Downstream Industry in Southwest 4.3 Market Forecast of Muscle Relaxant Drugs in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Muscle Relaxant Drugs 5.1 United States Economy Situation and Trend Overview 5.2 Muscle Relaxant Drugs Downstream Industry Situation and Trend Overview Chapter 6 Muscle Relaxant Drugs Market Competition Status by Major Players in United States 6.1 Sales Volume of Muscle Relaxant Drugs in United States by Major Players 6.2 Revenue of Muscle Relaxant Drugs in United States by Major Players 6.3 Basic Information of Muscle Relaxant Drugs by Major Players 6.3.1 Headquarters Location and Established Time of Muscle Relaxant Drugs Major Players 6.3.2 Employees and Revenue Level of Muscle Relaxant Drugs Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Muscle Relaxant Drugs Major Manufacturers Introduction and Market Data 7.1 Pfizer 7.1.1 Company profile 7.1.2 Representative Muscle Relaxant Drugs Product 7.1.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Pfizer 7.2 Allergan 7.2.1 Company profile 7.2.2 Representative Muscle Relaxant Drugs Product 7.2.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Allergan 7.3 Ipsen Group 7.3.1 Company profile 7.3.2 Representative Muscle Relaxant Drugs Product 7.3.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Ipsen Group 7.4 Teva Pharmaceuticals 7.4.1 Company profile 7.4.2 Representative Muscle Relaxant Drugs Product 7.4.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceuticals 7.5 Novartis 7.5.1 Company profile 7.5.2 Representative Muscle Relaxant Drugs Product 7.5.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Novartis 7.6 Johnson & Johnson 7.6.1 Company profile 7.6.2 Representative Muscle Relaxant Drugs Product 7.6.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.7 Takeda Pharmaceutical 7.7.1 Company profile 7.7.2 Representative Muscle Relaxant Drugs Product 7.7.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical 7.8 Sun Pharmaceutical Industries 7.8.1 Company profile 7.8.2 Representative Muscle Relaxant Drugs Product 7.8.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries 7.9 Merz Pharma 7.9.1 Company profile 7.9.2 Representative Muscle Relaxant Drugs Product 7.9.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Merz Pharma 7.10 Mylan 7.10.1 Company profile 7.10.2 Representative Muscle Relaxant Drugs Product 7.10.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Mylan 7.11 Fresenius Kabi 7.11.1 Company profile 7.11.2 Representative Muscle Relaxant Drugs Product 7.11.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Fresenius Kabi 7.12 Endo International 7.12.1 Company profile 7.12.2 Representative Muscle Relaxant Drugs Product 7.12.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Endo International 7.13 Par Sterile Products 7.13.1 Company profile 7.13.2 Representative Muscle Relaxant Drugs Product 7.13.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Par Sterile Products 7.14 Acorda Therapeutics 7.14.1 Company profile 7.14.2 Representative Muscle Relaxant Drugs Product 7.14.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Acorda Therapeutics 7.15 SteriMax Inc 7.15.1 Company profile 7.15.2 Representative Muscle Relaxant Drugs Product 7.15.3 Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of SteriMax Inc 7.16 Emcure Pharmaceuticals 7.17 Upsher-Smith Laboratories 7.18 Orient Pharma 7.19 Daewoong Pharmaceutical Chapter 8 Upstream and Downstream Market Analysis of Muscle Relaxant Drugs 8.1 Industry Chain of Muscle Relaxant Drugs 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Muscle Relaxant Drugs 9.1 Cost Structure Analysis of Muscle Relaxant Drugs 9.2 Raw Materials Cost Analysis of Muscle Relaxant Drugs 9.3 Labor Cost Analysis of Muscle Relaxant Drugs 9.4 Manufacturing Expenses Analysis of Muscle Relaxant Drugs Chapter 10 Marketing Status Analysis of Muscle Relaxant Drugs 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Skeletal Muscle Relaxant Drugs Table Advantage and Disadvantage of Facial Muscle Relaxant Drugs Table Consumption Volume of Muscle Relaxant Drugs in United States by Regions 2013-2017 Table Revenue of Muscle Relaxant Drugs in United States by Regions 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs in United States by Regions 2018-2023 Table Revenue of Muscle Relaxant Drugs in United States by Regions 2018-2023 Table Consumption Volume of Muscle Relaxant Drugs in United States by Types 2013-2017 Table Revenue of Muscle Relaxant Drugs in United States by Types 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in New England 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in The Midwest 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in The West 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in The South 2013-2017 Table Consumption Volume of Muscle Relaxant Drugs by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Muscle Relaxant Drugs in United States by Types 2018-2023 Table Revenue Forecast of Muscle Relaxant Drugs in United States by Types 2018-2023 Table Demand Volume of Muscle Relaxant Drugs in United States by Downstream Industry 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in New England 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The West 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in The South 2013-2017 Table Demand Volume of Muscle Relaxant Drugs by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Muscle Relaxant Drugs in United States by Downstream Industry 2018-2023 Table Sales Volume of Muscle Relaxant Drugs in United States by Major Players 2013-2017 Table Revenue of Muscle Relaxant Drugs in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Muscle Relaxant Drugs Major Players Table Employees and Revenue Level of Muscle Relaxant Drugs Major Players Table Representative Muscle Relaxant Drugs Product One of Pfizer Table Representative Muscle Relaxant Drugs Product Two of Pfizer Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Allergan Table Representative Muscle Relaxant Drugs Product Two of Allergan Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Allergan 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Ipsen Group Table Representative Muscle Relaxant Drugs Product Two of Ipsen Group Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Ipsen Group 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Teva Pharmaceuticals Table Representative Muscle Relaxant Drugs Product Two of Teva Pharmaceuticals Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceuticals 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Novartis Table Representative Muscle Relaxant Drugs Product Two of Novartis Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Johnson & Johnson Table Representative Muscle Relaxant Drugs Product Two of Johnson & Johnson Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Takeda Pharmaceutical Table Representative Muscle Relaxant Drugs Product Two of Takeda Pharmaceutical Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Sun Pharmaceutical Industries Table Representative Muscle Relaxant Drugs Product Two of Sun Pharmaceutical Industries Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Merz Pharma Table Representative Muscle Relaxant Drugs Product Two of Merz Pharma Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Merz Pharma 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Mylan Table Representative Muscle Relaxant Drugs Product Two of Mylan Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Mylan 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Fresenius Kabi Table Representative Muscle Relaxant Drugs Product Two of Fresenius Kabi Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Fresenius Kabi 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Endo International Table Representative Muscle Relaxant Drugs Product Two of Endo International Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Endo International 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Par Sterile Products Table Representative Muscle Relaxant Drugs Product Two of Par Sterile Products Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Par Sterile Products 2013-2017 Table Representative Muscle Relaxant Drugs Product One of Acorda Therapeutics Table Representative Muscle Relaxant Drugs Product Two of Acorda Therapeutics Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of Acorda Therapeutics 2013-2017 Table Representative Muscle Relaxant Drugs Product One of SteriMax Inc Table Representative Muscle Relaxant Drugs Product Two of SteriMax Inc Table Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin of SteriMax Inc 2013-2017